New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks
The latest research, in collaboration with the Mayo Clinic, West [...]
Trial Approval for New Pacemaker Aiming to Boost Recovery in Heart Failure
The system has shown a remarkable ability to boost performance [...]
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia
The ACHIEVE Study UK clinical trial is an open-label, phase [...]
Blood Filtration Offers Hope in the Fight Against Pancreatic Cancer
In a groundbreaking advancement of a novel cancer treatment, researchers [...]
Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC
The study includes two cohorts: Cohort A will enroll patients [...]
Phage-Derived Enzyme Targets E. faecalis Biofilms to Mitigate Acute Graft-Versus-Host Disease
In a recent study published in the journal Nature, our [...]
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’
Nicolas Poirier, Chief Executive Officer of OSE Immunotherapeutics, concludes: “We [...]
PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera
“Myeloproliferative neoplasms, including ET and PV, are chronic blood diseases [...]
Micro Medical Solutions | Achieves Milestone with 200th Enrollment in HEAL Registry
reg Sullivan, CEO of Micro Medical Solutions. “This milestone is [...]
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
The VenusP-Valve PROTEUS STUDY, abbreviated from Evaluation of the PerfoRmance [...]